Gladstone NOW: The Campaign Join Us on the Journey ✕
106 - 120 of 125 Results Clear All
By helping cells switch their type, we may have discovered a new way to repair damaged hearts, and potentially revolutionize the future of medicine.
Srivastava Lab Stem Cells/iPSCs
Todd McDevitt will use his background in biomedical engineering to improve and accelerate the development of human tissues from stem cells.
McDevitt Lab Stem Cells/iPSCs
With his unique combination of biology and chemistry, Gladstone’s Sheng Ding is quickly becoming a tour-de-force in the field of regenerative medicine.
Diabetes Ding Lab Stem Cells/iPSCs
New gift from long-time supporter William Younger is helping two top scientists repair damaged hearts and prevent damage in developing ones.
Donor Stories Cardiovascular Disease Bruneau Lab Srivastava Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—The power of regenerative medicine now allows scientists to transform skin cells into cells that closely resemble heart cells, pancreas cells, and even neurons.
Ding Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—The power of regenerative medicine appears to have turned science fiction into scientific reality—by allowing scientists to transform skin cells into cells that closely resemble beating heart cells.
Ding Lab Srivastava Lab Stem Cells/iPSCs
Gladstone’s innovative technique in stem cells could boost scientists’ ability to study—and ultimately cure—genetic disease.
Conklin Lab CRISPR/Gene Editing Stem Cells/iPSCs
A cure for type 1 diabetes has long eluded even the top experts. Not because they do not know what must be done—but because the tools did not exist to do it.
Diabetes Ding Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—A cure for type 1 diabetes has long eluded even the top experts. Not because they do not know what must be done—but because the tools did not exist to do it.
Diabetes Cardiovascular Disease Ding Lab Stem Cells/iPSCs
New study establishes platform for investigating chromosome regulation during early human development.
Yamanaka Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—There is no easy way to study diseases of the brain. Extracting brain cells, or neurons, from a living patient is difficult and risky, while examining a patient’s brain post-mortem usually only reveals the disease’s final stages.
Huang Lab Alzheimer’s Disease Stem Cells/iPSCs
SAN FRANCISCO, CA—In the aftermath of a heart attack, cells within the region most affected shut down. They stop beating. And they become entombed in scar tissue.
Srivastava Lab Stem Cells/iPSCs Stem Cells/iPSCs
SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes, next month will receive the Essey Award for his “Commitment to a Cure” from The ALS Association Golden West Chapter. This annual award represents the exceptional determination, spirit and dedication to the fight against amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
ALS Yamanaka Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—Gladstone Institutes’ Senior Investigator Shinya Yamanaka, MD, PhD, is one of 11 medical researchers to win a new, high-profile $3 million award from a group of high-tech sponsors, including the founders of Facebook and Google.
Stem Cells/iPSCs Yamanaka Lab Stem Cells/iPSCs
Shinya Yamanaka MD, PhD, a senior investigator at the Gladstone Institutes has won the 2012 Nobel Prize in Physiology or Medicine for his discovery of how to transform ordinary adult skin cells into cells that, like embryonic stem cells, are capable of developing into any cell in the human body.
Stem Cells/iPSCs Yamanaka Lab Stem Cells/iPSCs
